Literature DB >> 8679644

Effect of 17 beta-estradiol on chondrocyte membrane fluidity and phospholipid metabolism is membrane-specific, sex-specific, and cell maturation-dependent.

Z Schwartz1, P A Gates, E Nasatzky, V L Sylvia, J Mendez, D D Dean, B D Boyan.   

Abstract

In this study we examined the hypothesis that 17 beta-estradiol exerts both rapid and direct, nongenomic effects of cells in the endochondral pathway. To do this, we used a cell culture model in which chondrocytes at two distinct stages of cell maturation are isolated from the costochondral cartilage of male and female rats, and examined the short-term effect of 17 alpha- and 17 beta-estradiol on [14C]arachidonic acid turnover in the cell layer and phospholipase A2 specific activity in plasma membranes and extracellular matrix vesicles isolated from similarly prepared cultures. In addition, the effect of 17 alpha- and 17 beta-estradiol on plasma membrane and matrix vesicle membrane fluidity was assessed. The effect of hormone on arachidonic acid turnover was rapid, time- and concentration-dependent, stereo-specific, and cell maturation-specific. Only resting zone cells from female rats were affected, and only 17 beta-estradiol elicited a response. Similarly, only female rat resting zone chondrocytes exhibited a change in phospholipase A2 activity after a 24 h exposure to hormone, causing an increase in enzyme activity in the matrix vesicles, but not plasma membranes. When isolated membranes were incubated directly with hormone, membrane fluidity was decreased in both plasma membranes and matrix vesicles isolated from female rat resting zone chondrocyte cultures. This nongenomic effect was dose-dependent and stereo-specific and differentially expressed in the two membrane fractions with respect to time course and magnitude of response. These results support the hypothesis that 17 beta-estradiol has a rapid action on chondrocyte membrane lipid metabolism and suggest that specific membrane components, characteristic of a particular sex and state of cell maturation, are involved in the nongenomic effects of this sex hormone on isolated matrix vesicles and plasma membranes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8679644     DOI: 10.1016/0005-2736(96)00019-3

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  7 in total

1.  Intracellular calcium changes in neuronal cells induced by Alzheimer's beta-amyloid protein are blocked by estradiol and cholesterol.

Authors:  M Kawahara; Y Kuroda
Journal:  Cell Mol Neurobiol       Date:  2001-02       Impact factor: 5.046

2.  Effect of estradiol, diethylstilbestrol, and resveratrol on F0F1-ATPase activity from mitochondrial preparations of rat heart, liver, and brain.

Authors:  J L Kipp; V D Ramirez
Journal:  Endocrine       Date:  2001-07       Impact factor: 3.633

3.  Transforming growth factor-beta1 modulates chondrocyte responsiveness to 17beta-estradiol.

Authors:  E Nasatzky; D Grinfeld; B D Boyan; D D Dean; A Ornoy; Z Schwartz
Journal:  Endocrine       Date:  1999-12       Impact factor: 3.633

4.  The effects of 17 beta-estradiol on chondrocyte differentiation are modulated by vitamin D3 metabolites.

Authors:  Z Schwartz; Y Finer; E Nasatzky; W A Soskolne; D D Dean; B D Boyan; A Ornoy
Journal:  Endocrine       Date:  1997-10       Impact factor: 3.633

5.  Estradiol Inhibits ER Stress-Induced Apoptosis in Chondrocytes and Contributes to a Reduced Osteoarthritic Cartilage Degeneration in Female Mice.

Authors:  Rita Dreier; Thomas Ising; Markus Ramroth; Yvonne Rellmann
Journal:  Front Cell Dev Biol       Date:  2022-05-20

6.  Gender differences in cholesterol nucleation in native bile: estrogen is a potential contributory factor.

Authors:  Angela C Brown; Steven P Wrenn; Nandita Suresh; William C Meyers; Mohammad Z Abedin
Journal:  J Membr Biol       Date:  2009-11-07       Impact factor: 1.843

7.  Neurosteroids block the increase in intracellular calcium level induced by Alzheimer’s β-amyloid protein in long-term cultured rat hippocampal neurons.

Authors:  Midori Kato-Negishi; Masahiro Kawahara
Journal:  Neuropsychiatr Dis Treat       Date:  2008-02       Impact factor: 2.570

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.